Global Immunoassay Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Immunoassay Industry Expected To Reach By 2029, Starting From 2025 Levels?

Recent years have shown consistent expansion within the immunoassay market, projected to increase from its 2024 valuation of $35.81 billion to reach $37.32 billion in 2025, reflecting a 4.2% CAGR; this upward trajectory during the past period stemmed from factors such as the rising incidence of various diseases, an expanding elderly demographic, sudden outbreaks of infectious ailments, the advancement of point-of-care diagnostic procedures, and boosted financial support for research endeavors.

Projections indicate robust expansion for the immunoassay sector over the forthcoming years, with its valuation set to reach $49.4 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.3%. This upswing during the forecasted timeframe is fundamentally driven by advances in personalized medicine, the broadening reach into developing economies, heightened focus on pandemic readiness, advancements in cancer diagnosis, and a discernible movement towards self-administered testing at home. Key developments anticipated throughout this period encompass the drive toward standardizing regulations across different regions, the development of immunoassays capable of multiple functions simultaneously, bespoke services for assay development, incorporating assays with wearable technology, and the continued reduction in the physical size of diagnostic tests.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Which Drivers Are Shaping The Immunoassay Industry’s Market Share?

The rising prevalence of both long-term conditions and acute infections is anticipated to be a primary catalyst for the expansion of the immunoassay market moving forward. Chronic ailments are generally defined as conditions lasting a year or longer that either demand ongoing medical intervention, impede daily functioning, or both, while infectious diseases stem from pathogenic agents like microbes, viral particles, fungal spores, or parasites; the human body hosts a vast array of such organisms, and the contagiousness of many infectious diseases allows for interpersonal transmission. Immunoassays serve as a crucial tool for identifying a spectrum of these infectious and chronic health issues, evidenced by projections from the National Institutes of Health (NIH), an American biomedical research entity, indicating that within the United States by 2050, the count of individuals aged 50 and above suffering from a minimum of one chronic disease is projected to nearly double, increasing by 99.5% from 71.522 million documented in 2020 to 142.66 million; furthermore, the population experiencing multimorbidity is slated for an 91.16% escalation, moving from 7.8304 million in 2020 to 14.968 million by 2050, thus cementing the growing burden of infectious and chronic conditions as a significant market stimulant.

What Are The Major Segments Identified In The Immunoassay Market?

The immunoassaymarket covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Subsegments:

1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents

2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers

3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services

Which Competitive Trends Are Defining The Immunoassay Market Structure?

A significant movement within the immunoassay sector revolves around enhancing products, with leading participants striving to improve their standing through the introduction of novel offerings. A case in point is the introduction by Getein Biotech Inc., the China-based developer, manufacturer, seller, and service provider for in vitro diagnostic tools and reagents, of the MAGICL 6000 at the MEDICA 2022 exhibition in November 2022. This device represents a state-of-the-art, portable chemiluminescence immunoassay analyzer, perfectly suited for facilities requiring a streamlined, single-step chemiluminescence process amidst medium to high testing volumes. Characterized by its compact design and exceptional operational speed, this unit provides fully automated functionality, boasting the fastest testing throughput available for analyzers of its compact dimensions.

Who Are The Key Multinational Companies Dominating The Immunoassay Market?

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

How Does The Immunoassay Market Perform Across Key Geographic Regions?

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp

Browse Through More Reports Similar to the Global Immunoassay Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795